MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2026 International Congress

    Effects of Manual Therapy on Hand Dexterity in Children Aged 4–8 Years: A Prospective Interventional Study

    TV. Voloshyn (TRUSKAVETS, Ukraine)

    Objective: This study aimed to evaluate the effect of a structured manual therapy program on hand dexterity in young children. Background: Impaired hand dexterity is…
  • 2026 International Congress

    From Vision to Reality: Nursing Driven Implementation, Policy, and Safety Framework for Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in a Tertiary Movement Disorder Centre

    E. de Freitas, S. Mittal (Abu Dhabi, United Arab Emirates)

    Objective: To describe the development of nursing roles, policies, and safety processes supporting implementation of foslevodopa/foscarbidopa infusion therapy for advanced Parkinson’s disease in a tertiary…
  • 2026 International Congress

    Taekwondo Training with External Focus of Attention as a Complex Motor Intervention in Parkinson’s Disease: A Pilot Study

    B. Kim, M. Torbitt, J. Lombardi, A. Deblois (Syracuse, USA)

    Objective: To examine the feasibility and effects of an 8-week Taekwondo (TKD) training emphasizing multidirectional, externally focused, and cognitively challenging motor training on balance and mobility in people with Parkinson’s disease (PwPD). Background: Conventional…
  • 2026 International Congress

    The Therapeutic Landscape of SSPE: A Systematic Review of Antiviral and Immunomodulatory Modalities

    V. Jadhav, S. Errabelly, M. Tripathi, D. Dash, P. Mohapatra, E. Arunmozhimaran (Lucknow, India)

    Objective: To systematically map the global therapeutic landscape of SSPE interventions, specifically characterizing drug regimens, dosages, administration routes, and monotherapy versus combination protocols. Background: SSPE…
  • 2026 International Congress

    Interventions in Friedreich’s Ataxia and their Influence on Patient-centric Outcomes: A Systematic Review

    D. Sarwinska, M. Buchholz, A. Iskandar, M. Grobe-Einsler, T. Klockgether, J. Faber, B. Michalowsky (Greifswald, Germany)

    Objective: The presented systematic review summarizes available pharmacological and non‑pharmacological interventions for patients with Friedreich's ataxia, their outcomes, and alignment with patient‑centered health domains as…
  • 2026 International Congress

    ALPHA-FIT: Slowing cognitive decline in alpha-synucleinopathies by enhancing physical activity

    E. Fitzgibbon, M. Wildt, T. Oosterhof, M. Rodemann, A. Ophey, E. Prins, S. Darweesh, A. Stefani, M. Sommerauer (Bonn, Germany)

    Objective: To evaluate the effects of increased physical activity on cognitive decline in patients with isolated REM sleep behavior disorder (iRBD). Background: Physical activity has…
  • 2026 International Congress

    Digital cognitive training and promoting a healthy lifestyle as a booster for cognitive reserve in prodromal Parkinson’s disease?

    A. Ophey, S. Röttgen, K. Kufer, J. Pauquet, D. Scharfenberg, P. Armbrust, A. Kammerzell, N. Knopf, S. Kollath, P. Sommer, CEJ. Doppler, E. Farrher, A. Seger, NJ. Shah, D. Zopfs, K. Reetz, GR. Fink, M. Sommerauer, E. Kalbe (Cologne, Germany)

    Objective: To investigate predictors of responsiveness to a multimodal cognitive training intervention in individuals with isolated REM sleep behavior disorder (iRBD). Background: The prodromal phase…
  • 2026 International Congress

    Slow-SPEED-US: Initiation of a Remote Exercise Trial in LRRK2 and GBA1 Carriers

    R. Schneider, T. Oosterhof, E. Prins, M. Kmiecik, S. Aslibekyan, N. Hetrick, M. Porto, K. Schmier, C. Dorney, A. Noyce, B. Bloem, S. Darweesh (Rochester, USA)

    Objective: To describe the launch of Slow-SPEED-US, presenting recruitment results and baseline characteristics of the enrolled subsample. Background: Slow-SPEED-US is part of a network of…
  • 2026 International Congress

    EAGLE: Protocol for a Phase 3 Study to Evaluate the Efficacy and Safety of Two Mobile Applications Combined with Immediate-Release CD/LD for the Management of Idiopathic Parkinson’s Disease

    S. Oren, A. Amedi, S. Molcho, D. Ziv, O. Shoval, S. Erlich (Ramat Gan, Israel)

    Objective: To evaluate the efficacy and safety of Hybridopa A and Hybridopa B, combination products of immediate-release carbidopa/levodopa (IR CD/LD) and therapeutic mobile applications, in adults with idiopathic Parkinson’s disease (PD) on a…
  • 2026 International Congress

    The Effects of Bright Light Therapy on Improving Sleep Disorders in Parkinson’s Disease

    WY. Xie, JM. Duan, WX. Duan, Y. Chen, F. Wang, Y. Shen, CF. Liu (Suzhou, China)

    Objective: To explore the effects of bright light therapy (BLT) on improving sleep disorders in Parkinson‘s disease (PD). Background: Sleep disorders are common clinical symptoms…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 29
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley